
Sign up to save your podcasts
Or


Seth M. Pollack, MD, of the Fred Hutchinson Cancer Research Center, discusses immunotherapy for sarcoma and how varying microenvironments in sarcoma subtypes impact response to immunotherapy.
By American Society of Clinical Oncology (ASCO)4.6
5656 ratings
Seth M. Pollack, MD, of the Fred Hutchinson Cancer Research Center, discusses immunotherapy for sarcoma and how varying microenvironments in sarcoma subtypes impact response to immunotherapy.

321 Listeners

504 Listeners

39 Listeners

65 Listeners

756 Listeners

121 Listeners

2,262 Listeners

818 Listeners

187 Listeners

46 Listeners

32 Listeners

828 Listeners

59 Listeners

195 Listeners

45 Listeners